Fresenius Medical Care AG & Co. KGaA (FME.DE)
EUR 45.06
(-0.09%)
EUR 45.06
(-0.09%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 4.92 Billion EUR | -7.25% |
| 2022 | 5.31 Billion EUR | 4.59% |
| 2021 | 5.07 Billion EUR | -8.31% |
| 2020 | 5.53 Billion EUR | 2.61% |
| 2019 | 5.39 Billion EUR | 4.68% |
| 2018 | 5.15 Billion EUR | -14.14% |
| 2017 | 6 Billion EUR | 9.25% |
| 2016 | 5.49 Billion EUR | 12.71% |
| 2015 | 4.87 Billion EUR | 18.68% |
| 2014 | 4.1 Billion EUR | 19.73% |
| 2013 | 3.43 Billion EUR | -1.37% |
| 2012 | 3.47 Billion EUR | -0.25% |
| 2011 | 3.48 Billion EUR | 11.92% |
| 2010 | 3.11 Billion EUR | 16.53% |
| 2009 | 2.67 Billion EUR | 2.59% |
| 2008 | 2.6 Billion EUR | 13.26% |
| 2007 | 2.3 Billion EUR | 5.57% |
| 2006 | 2.18 Billion EUR | 10.7% |
| 2005 | 1.96 Billion EUR | 28.0% |
| 2004 | 1.53 Billion EUR | 5.96% |
| 2003 | 1.45 Billion EUR | -7.98% |
| 2002 | 1.57 Billion EUR | -14.34% |
| 2001 | 1.84 Billion EUR | 17.96% |
| 2000 | 1.56 Billion EUR | -7.56% |
| 1999 | 1.68 Billion EUR | 25.48% |
| 1998 | 1.34 Billion EUR | -54.53% |
| 1997 | 2.96 Billion EUR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 1.17 Billion EUR | -13.03% |
| 2024 Q3 | 1.14 Billion EUR | -1.76% |
| 2024 Q2 | 1.16 Billion EUR | -0.65% |
| 2023 Q4 | 1.35 Billion EUR | 9.85% |
| 2023 Q2 | 1.19 Billion EUR | 4.18% |
| 2023 Q3 | 1.22 Billion EUR | 2.66% |
| 2023 Q1 | 1.14 Billion EUR | -14.75% |
| 2023 FY | 4.92 Billion EUR | -7.25% |
| 2022 Q1 | 1.25 Billion EUR | -4.62% |
| 2022 FY | 5.31 Billion EUR | 4.59% |
| 2022 Q2 | 1.34 Billion EUR | 6.99% |
| 2022 Q4 | 1.34 Billion EUR | -0.78% |
| 2022 Q3 | 1.35 Billion EUR | 0.93% |
| 2021 Q1 | 1.2 Billion EUR | -12.18% |
| 2021 Q2 | 1.28 Billion EUR | 6.41% |
| 2021 Q3 | 1.26 Billion EUR | -1.31% |
| 2021 Q4 | 1.31 Billion EUR | 4.09% |
| 2021 FY | 5.07 Billion EUR | -8.31% |
| 2020 Q4 | 1.37 Billion EUR | 0.51% |
| 2020 Q1 | 1.41 Billion EUR | -2.97% |
| 2020 Q2 | 1.43 Billion EUR | 1.79% |
| 2020 Q3 | 1.36 Billion EUR | -4.8% |
| 2020 FY | 5.53 Billion EUR | 2.61% |
| 2019 Q2 | 1.33 Billion EUR | 5.19% |
| 2019 Q4 | 1.45 Billion EUR | 8.02% |
| 2019 Q3 | 1.34 Billion EUR | 1.13% |
| 2019 FY | 5.39 Billion EUR | 4.68% |
| 2019 Q1 | 1.26 Billion EUR | -8.31% |
| 2018 Q3 | 1.26 Billion EUR | -2.83% |
| 2018 Q2 | 1.3 Billion EUR | 8.42% |
| 2018 Q1 | 1.2 Billion EUR | -19.42% |
| 2018 Q4 | 1.38 Billion EUR | 8.89% |
| 2018 FY | 5.15 Billion EUR | -14.14% |
| 2017 Q3 | 1.42 Billion EUR | -4.73% |
| 2017 FY | 6 Billion EUR | 9.25% |
| 2017 Q4 | 1.49 Billion EUR | 4.83% |
| 2017 Q2 | 1.49 Billion EUR | -6.07% |
| 2017 Q1 | 1.59 Billion EUR | 5.15% |
| 2016 Q1 | 1.16 Billion EUR | -13.41% |
| 2016 Q4 | 1.51 Billion EUR | 15.4% |
| 2016 Q3 | 1.31 Billion EUR | 4.33% |
| 2016 Q2 | 1.25 Billion EUR | 8.14% |
| 2016 FY | 5.49 Billion EUR | 12.71% |
| 2015 Q3 | 1.22 Billion EUR | 6.17% |
| 2015 FY | 4.87 Billion EUR | 18.68% |
| 2015 Q2 | 1.15 Billion EUR | 5.78% |
| 2015 Q1 | 1.09 Billion EUR | -5.97% |
| 2015 Q4 | 1.34 Billion EUR | 9.34% |
| 2014 Q1 | 786.81 Million EUR | -11.03% |
| 2014 Q4 | 1.16 Billion EUR | 14.55% |
| 2014 FY | 4.1 Billion EUR | 19.73% |
| 2014 Q2 | 887.94 Million EUR | 12.85% |
| 2014 Q3 | 1.01 Billion EUR | 14.32% |
| 2013 Q2 | 890.37 Million EUR | 2.77% |
| 2013 Q1 | 866.4 Million EUR | -3.98% |
| 2013 FY | 3.43 Billion EUR | -1.37% |
| 2013 Q4 | 884.37 Million EUR | 2.07% |
| 2013 Q3 | 866.4 Million EUR | -2.69% |
| 2012 Q4 | 902.34 Million EUR | 4.16% |
| 2012 FY | 3.47 Billion EUR | -0.25% |
| 2012 Q1 | 801.73 Million EUR | -23.66% |
| 2012 Q2 | 890.1 Million EUR | 11.02% |
| 2012 Q3 | 866.27 Million EUR | -2.68% |
| 2011 FY | 3.48 Billion EUR | 11.92% |
| 2011 Q4 | 1.05 Billion EUR | 23.62% |
| 2011 Q3 | 849.54 Million EUR | 9.62% |
| 2011 Q2 | 774.97 Million EUR | 5.71% |
| 2011 Q1 | 733.11 Million EUR | -17.88% |
| 2010 Q3 | 773.75 Million EUR | -6.8% |
| 2010 Q1 | 718.29 Million EUR | -8.02% |
| 2010 Q2 | 830.2 Million EUR | 15.58% |
| 2010 FY | 3.11 Billion EUR | 16.53% |
| 2010 Q4 | 892.78 Million EUR | 15.38% |
| 2009 Q2 | 664.08 Million EUR | 2.17% |
| 2009 Q3 | 668.21 Million EUR | 0.62% |
| 2009 Q4 | 780.88 Million EUR | 16.86% |
| 2009 FY | 2.67 Billion EUR | 2.59% |
| 2009 Q1 | 649.96 Million EUR | -7.13% |
| 2008 Q2 | 587.08 Million EUR | 8.4% |
| 2008 FY | 2.6 Billion EUR | 13.26% |
| 2008 Q4 | 699.82 Million EUR | 8.5% |
| 2008 Q3 | 644.99 Million EUR | 9.86% |
| 2008 Q1 | 541.56 Million EUR | -6.3% |
| 2007 Q3 | 587.2 Million EUR | -5.08% |
| 2007 Q2 | 618.63 Million EUR | 5.37% |
| 2007 FY | 2.3 Billion EUR | 5.57% |
| 2007 Q1 | 587.13 Million EUR | 5.11% |
| 2007 Q4 | 577.96 Million EUR | -1.57% |
| 2006 Q2 | 570.55 Million EUR | 19.59% |
| 2006 Q4 | 558.59 Million EUR | -5.57% |
| 2006 FY | 2.18 Billion EUR | 10.7% |
| 2006 Q3 | 591.57 Million EUR | 3.68% |
| 2006 Q1 | 477.09 Million EUR | -11.82% |
| 2005 FY | 1.96 Billion EUR | 28.0% |
| 2005 Q4 | 541.04 Million EUR | 9.85% |
| 2005 Q3 | 492.53 Million EUR | 1.59% |
| 2005 Q2 | 484.83 Million EUR | 16.61% |
| 2005 Q1 | 415.77 Million EUR | 32.85% |
| 2004 FY | 1.53 Billion EUR | 5.96% |
| 2004 Q4 | 312.97 Million EUR | -24.74% |
| 2004 Q2 | 430.53 Million EUR | 10.06% |
| 2004 Q3 | 415.85 Million EUR | -3.41% |
| 2004 Q1 | 391.18 Million EUR | 23.34% |
| 2003 Q2 | 384.8 Million EUR | 0.84% |
| 2003 Q1 | 381.61 Million EUR | 6.43% |
| 2003 FY | 1.45 Billion EUR | -7.98% |
| 2003 Q4 | 317.14 Million EUR | -20.23% |
| 2003 Q3 | 397.55 Million EUR | 3.31% |
| 2002 Q2 | 410.12 Million EUR | -5.26% |
| 2002 Q3 | 424.87 Million EUR | 3.6% |
| 2002 Q4 | 358.57 Million EUR | -15.6% |
| 2002 FY | 1.57 Billion EUR | -14.34% |
| 2002 Q1 | 432.9 Million EUR | -14.7% |
| 2001 FY | 1.84 Billion EUR | 17.96% |
| 2001 Q4 | 507.5 Million EUR | 11.12% |
| 2001 Q3 | 456.69 Million EUR | -5.35% |
| 2001 Q2 | 482.52 Million EUR | 8.44% |
| 2001 Q1 | 444.95 Million EUR | 485.49% |
| 2000 FY | 1.56 Billion EUR | -7.56% |
| 2000 Q4 | 75.99 Million EUR | -88.7% |
| 2000 Q3 | 672.35 Million EUR | 75.62% |
| 2000 Q2 | 382.85 Million EUR | -13.57% |
| 2000 Q1 | 442.94 Million EUR | -60.55% |
| 1999 Q1 | 891.88 Million EUR | 11.96% |
| 1999 Q2 | 927.36 Million EUR | 3.98% |
| 1999 Q3 | 897.96 Million EUR | -3.17% |
| 1999 Q4 | 1.12 Billion EUR | 25.02% |
| 1999 FY | 1.68 Billion EUR | 25.48% |
| 1998 Q3 | 755.45 Million EUR | -4.93% |
| 1998 FY | 1.34 Billion EUR | -54.53% |
| 1998 Q1 | 819.87 Million EUR | 1.07% |
| 1998 Q4 | 796.62 Million EUR | 5.45% |
| 1998 Q2 | 794.62 Million EUR | -3.08% |
| 1997 Q4 | 811.18 Million EUR | 12.16% |
| 1997 Q2 | 702.26 Million EUR | 2.99% |
| 1997 FY | 2.96 Billion EUR | 0.0% |
| 1997 Q1 | 681.89 Million EUR | 0.0% |
| 1997 Q3 | 723.21 Million EUR | 2.98% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Fresenius SE & Co. KGaA | 5.05 Billion EUR | 2.637% |
| LIMES Schlosskliniken AG | 13.58 Million EUR | -36149.811% |
| M1 Kliniken AG | 26.66 Million EUR | -18369.971% |
| Maternus-Kliniken Aktiengesellschaft | 11.9 Million EUR | -41276.382% |
| MEDICLIN Aktiengesellschaft | 144.11 Million EUR | -3317.097% |
| RHÖN-KLINIKUM Aktiengesellschaft | 198.49 Million EUR | -2381.04% |
| VITA 34 AG | 28.24 Million EUR | -17335.976% |